To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive
a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles.
Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive
evaluation and ratings from patients.
The epigenetic-like role of oxidative DNA lesions as transcriptional regulators of cancer-associated genes through DNA repair
DNA repair strategies used to complete oxidative lesion repair in G-quadruplex forming DNA sequences
DNA structural dynamics in response to DNA damage and repair in G-quadruplexes and other non-canonical DNA secondary structures
Projects in the Whitaker lab aim to elucidate the molecular mechanisms coupling two key biological responses to oxidative DNA damage within G-quadruplex forming sequences. Specifically, base excision repair (BER) and the epigenic-like transcriptional regulation of key tumor suppressors and oncogenes. The long-term goal is to identify molecular targets that can be exploited to improve cancer therapies.
The primary techniques utilized in the lab include structural biology (X-ray crystallography, Cryo-EM), nucleic acid enzymology, single-molecule fluorescence microscopy, as well as human cell-based assays.
Deposited and published 30 X-ray crystal structures in the PDB (Protein Data Bank).
Xun Lu*, Sarah L. Lucas*, Amy M. Whitaker, Brittany Ripley, Todd M. Washington, Christopher B. Stanley, Bret D. Frequential, Samuel H. Wilson, and Matthew J. Cuneo. Deconvolution of complex molecular DNA repair assemblies into individual components using small-angle neutron scattering. *Co-first authors (In preparation)
Amy M. Whitaker, Wesley J. Stark, Bret. D. Freudenthal. AP-Endonuclease 1 (APE1) cleansing of DNA dirty ends. (under review at Nucleic Acids Research)
Max S. Fairlamb, Amy M. Whitaker, Fletcher E. Bain, Maria Spies, Bret D. Freudenthal. 2021. Construction of a Three-Color Prism-Based TIRF Microscope to study the Interactions and Dynamics of Macromolecules. Biology (Basel). PMID: 34201434.
Amy M. Whitaker, Bret D. Freudenthal. 2020. History of DNA polymerase β X-ray crystallography. DNA Repair (Amst). PMID: 33087265.
Amy M. Whitaker, Wesley J. Stark, Tony S. Flynn, Bret D. Freudenthal. 2020. Molecular and structural characterization of disease-associated APE1 polymorphisms. DNA Repair (Amst). Jul-Aug:91-92. PMID: 32454397.
Nicole M. Hoitsma, Amy M. Whitaker, Emily C. Beckwitt, S. Jang, P. Agarwal, Bennett Van Houten, Bret D. Freudenthal. 2020. AP-endonuclease 1 sculpts DNA through an anchoring tyrosine residue on the DNA intercalating loop. Nucleic Acid Res. Online ahead of print. PMID: 32542366.
Daniel R. McNeill, Amy M. Whitaker, Wesley J. Stark, Jennifer L. Illuzzi, Peter J. McKinnon, Bret D. Freudenthal, David M. Wilson III. 2020. Functions of APE1 that are critical to cell viability and genotoxin resistance. Mutagenesis. 35:27-38. PMID: 31816044.
Note: This paper was awarded paper of the year by Mutagenesis
Nicole M. Hoitsma*, Amy M. Whitaker*, Matthew A. Schaich, Mallory R. Smith, Max S. Fairlamb, and Bret D. Freudenthal. 2020. Structure and function relationships in mammalian DNA polymerases. Cell Mol Life Sci. 77:35-59. PMID: 31722068. *Co-first authors
Amy M. Whitaker, Rockann E. Mosser, Mandar, T. Naik, and Gregory D. Reinhart. 2019. Propagation of the Allosteric Signal in Bacillus stearothermophilus Phosphofructokinase Examined by Methyl-TROSY NMR. Biochemistry. PMID: 31478644.
Amy M. Whitaker, Bret D. Freudenthal. 2018. APE1: A skilled nucleic acid surgeon. DNA Repair (Amst). 71:93-100. PMID: 30170830.
Max S. Fairlamb*, Amy M. Whitaker*, Bret D. Freudenthal. 2018. Apurinic/apyrimidinic (AP) endonuclease 1 processing of AP sites with 5' mismatches. Acta Crystallogr D Struct Biol. 74(Pt 8):760-768. PMID: 30082511. *Co-first authors
Amy M. Whitaker, Tony S. Flynn, Bret D. Freudenthal. 2018. Molecular snapshots of APE1 proofreading mismatches and removing DNA damage. Nature Communications. 9:399. PMID: 9374164.
Amy M. Whitaker*, Mallory S. Smith*, Matthew A. Schaich, Bret D. Freudenthal. 2017. Capturing a mammalian DNA polymerase extending from an oxidized nucleotide. Nucleic Acids Res. PMID: 28449123. *Co-first Authors
Amy M. Whitaker*, Matthew A. Schaich*, Mallory S. Smith, Tony S. Flynn, Bret D. Freudenthal. 2017. Base excision repair of oxidative DNA damage: from mechanism to disease. Front Biosci (Landmark Ed). 22:1493-1522. PMID: 28199214. *Co-first authors
Amy M. Whitaker, Gregory D. Reinhart. 2016. The effect of introducing small cavities on the allosteric inhibition of phosphofructokinase from Bacillus stearothermophilus. Arch Biochem Biophys. 607:1-6. PMID: 27477958.
A postdoctoral position is available starting immediately for a highly motivated, enthusiastic individual in the NIH-funded group of Dr. Amy Whitaker in the Molecular Therapeutics Program, Fox Chase Cancer Center. The Whitaker group focuses on investigating pressing questions at the intersection of DNA damage, DNA repair, and transcriptional regulation. Potential projects aim to elucidate the mechanistic details by which the repair of oxidative DNA damage within gene regulatory regions of the genome modulate the transcription of key tumor suppressor and oncogenes. The long-term goal is to identify molecular targets that can be exploited to improve cancer therapies. The primary techniques utilized will include structural biology (X-ray crystallography, Cryo-EM), nucleic acid enzymology, single-molecule fluorescence microscopy, as well as human cell-based assays. For more information, please see our website at http://www.dnamywhitakerlab.com/.
Interested applicants should have experience publishing peer reviewed manuscripts and have expertise in either structural biology, single-molecule fluorescence, enzyme kinetics, cancer biology, tissue culture, and/or biochemistry. In addition, applicants should possess excellent written and verbal communication skills, and the ability to conduct research both independently and collaboratively. Candidates must possess a doctoral level degree in a relevant field. Fox Chase postdoctoral fellows enjoy a generous benefits package and salary for this position is set by NIH guidelines and commensurate with experience. Though the position is fully funded, the successful candidate will be mentored and encouraged to apply for additional financial support.
ABOUT THE TRAINING ENVIRONMENT
As one of the four original cancer centers to receive comprehensive designation from the National Cancer Institute, Fox Chase Cancer Center has been at the forefront of cancer research for almost 90 years. We are home to excellent research facilities, top clinicians and scientists, and outstanding patient care. Our singular focus on cancer, which couples discovery science with state of the art clinical care and population health, remains the foundation of our work.
In addition to the robust training program, scientists at Fox Chase Cancer Center benefit from being part of the rich scientific and biotech environment in the Philadelphia region. Many of our former trainees are now employees (and contacts) at nearby institutions and companies, including The Wistar Institute, Merck, GSK, AACR, and numerous others.
To apply, please email a CV, a cover letter briefly describing research interest(s) and goals, and the name of at least three references to Dr. Amy Whitaker ([email protected]).
The following ratings and reviews are based on verified feedback collected from independently administered
patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions.
Patient identities are withheld to ensure confidentiality and privacy.
Learn more about our Patient Experience Ratings.